TY - JOUR T1 - What is the relationship between validated frailty scores and mortality for adults with COVID-19 in acute hospital care? A systematic review JF - medRxiv DO - 10.1101/2020.11.13.20231365 SP - 2020.11.13.20231365 AU - Theodore D. Cosco AU - John Best AU - Daniele Bryden AU - Daniel Davis AU - Kevin Wagner AU - Suzanne Arkil AU - Simon Conroy Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/16/2020.11.13.20231365.abstract N2 - Background & aim The COVID-19 pandemic has had a disproportionate impact upon older people; the frailty construct has been used to assess risk of poor outcomes in many settings. The aim of this systematic review was to quantify the association between frailty and COVID-19 in relation to mortality in hospitalised patients.Methods Medline, Embase and the grey literature were searched for papers from inception to 10th September 2020. Screening (and grading) was undertaken by two reviewers according to pre-defined inclusion and exclusion criteria. Met-analysis was not possible so the result were summarised narratively.Results 2276 papers were screened resulting in 16 being included in the review. All studies were from Europe, mostly the UK; the median sample size was 308.5, mean age of participants 78.7 and 42% were female. 15/16 used the Clinical Frailty Scale; reported mortality ranged from 19 to 65%. Most, but not all studies showed an association between increasing frailty and a greater risk of dying. Two studies indicated a sub-additive relationship between frailty, COVID-19 and death, and one study showed no increase in dying.Conclusions This review showed that whilst many studies have shown an association between an increased risk of COVID-19 related death with increasing frailty, other studies demonstrate a more nuanced understanding of frailty and outcomes in COVID-19 is needed. Clinicians should exert caution in placing too much emphasis on the influence of frailty alone when discussing likely prognosis in older people with COVID-19 infection.Key points Frailty is being used to assess the risk of dying from COVID-19Researchers should ensure that frailty scales are used as designed when planning and reporting future research.Emerging studies demonstrate a complex relationship between frailty and COVID-19 related deathsClinicians should exert caution in placing too much emphasis on the influence of frailty in older people with COVID-19Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=200445 Funding StatementDaniel Davis is funded through a Wellcome Intermediate Clinical Fellowship (WT107467). Theodore D Cosco is funded through a Michael Smith Foundation for Health Research Scholar Award (SCH-2020-0490).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval was required for this work as it was a systematic review of published studies.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the primary studies are already available in the public domain and referenced in the manuscript. ER -